I nvasive coronary angiography is the standard clinical means for depicting the coronary arteries and is the "gold standard" for diagnosing coronary artery disease (CAD). Since its implementation over 30 years ago, more than 2 million coronary angiograms have been made yearly in North America. Coronary angiography requires high-level technical expertise and technology, which makes it relatively expensive and limits it to a select population. Angiography also has its limitations, since only the lumen is displayed ("luminology") and the information it provides about the coronary plaque is not extensive. However, new tomographic methods for cardiovascular imaging such as intravascular ultrasonography (IVUS), coronary CT angiography and MRI can assess the atherosclerotic plaques responsible for early, "silent" CAD. In this article, we review the current and potential future clinical applications of these 3 tools for the visual detection of atherosclerotic CAD.
Intravascular ultrasonographyIVUS has become a powerful complementary tool to measure and characterize coronary vessels and atherosclerotic plaques. An invasive procedure, IVUS produces images with a small ultrasound transducer mounted on a catheter similar to the standard catheters employed in coronary angioplasty. The catheter is advanced over the wire inside the coronary artery until it reaches a position distal to the segment to be studied. A series of tomographic images of the coronary artery are obtained as the catheter is slowly pulled back. Each IVUS image displays a 360°cross-sectional view of the layers of the coronary artery (intima, media and adventitia) as well as the lumen (Fig. 1A,B). Modern devices can perform 3-dimensional reconstructions online that provide information about the length, volume and reference landmarks of a plaque.Standard radiographic coronary angiography provides a single-plane "shadow" of the vascular lumen; its ability to accurately and reproducibly measure the degree of stenosis and to characterize plaque morphology is limited.1-3 Extensive experience in our and other centres has shown that IVUS is a safe, accurate and reproducible alternative method for assessing the severity and morphology of lesions.4,5 The types of plaques detectable by IVUS are summarized in Box 1.
Clinical useThe best-studied clinical application of IVUS is in the placement of stents into coronary vessels (Fig. 1C,D, Fig. 2, Fig. 3). Stenting has revolutionized the treatment of atherosclerotic CAD. Restenosis inside the stent, which occurs in 5%-20% of cases (depending on the complexity of the lesion and underlying risk factors), nevertheless remains a major shortcoming. IVUS has played an important role in the understanding of stent failures.In-stent restenosis is typically caused by neointimal hyperplasia: new fibrotic tissue that grows inside the stent and obstructs the lumen. Serial IVUS studies performed in cases of bare-metal stent failure have shown that underexpansion of the stent is an important cause of early failure.6 If the stent is poorl...